Brainstem vagus nuclei evoked potentials - A new diagnostic method in neuropsychiatry?;Evozierte potenziale der vagus-kerngebiete im hirnstamm - Eine neue diagnostische methode in der neuropsychiatrie?

Nervenheilkunde

Volumn 25, Issue 8, 2006, Pages 669-673

  Fallgatter, Andreas J ^a   Polak, T ^a   Metzger, F ^a   Richter, M M ^a   Baehne, C G ^a   Plichta, M M ^a   Scheuerpflug, P ^a   Ehlis, A C ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Dementia; Depression; Parkinson's disease; Vagus evoked potentials

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; EPILEPSY; EVOKED BRAIN STEM RESPONSE; HUMAN; NEUROPROTECTION; NEUROPSYCHIATRY; PARKINSON DISEASE; VAGUS NERVE NUCLEUS; VAGUS NERVE STIMULATION;

EID: 33846564937     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1626767     Document Type: Article

References (12)

1. Bajbouj M, Heuser I. Vagus nerve stimulation, repetitive transcranial magnetic stimulation, and electroconvulsive therapy in the treatment of depressive disorders. Nervenarzt 2005; 76: 28-35.
2. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318: 121-34.
3. Braak H, Rüb U, Gai WP, DelTredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003; 110: 517-36.
4. Fallgatter AJ, Neuhauser B, Herrmann MJ, Ehlis AC, Wagener A, Scheuerpflug P, Reiners K, Riederer P. Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J Neural Transm 2003; 110: 1437-43.
5. Fallgatter AJ, Ehlis AC, Ringel TM, Herrmann MJ. Age effect on far field potentials from the brain stem after transcutaneous vagus nerve stimulation. Int J Psychophys 2005; 56: 37-43.
6. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
7. Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev 2005; 29: 493-500.
8. Kalbe E, Kessler J, Calabrese P, Smith R, Passmore AP, Brand M, Bullock R. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004; 19: 136-43.
9. Maurer K, Lowitsch K, Stöhr M (Hrsg). Evozierte Potenziale. AEP-VEP-SEP. 2. Auflage. Stuttgart: Enke 1990.
10. Parvizi J, Van Hoesen GW, Damasio A. The selective vulnerability of brainstem nuclei to Alzheimer's disease. Ann Neurol 2001; 49: 53-66.
11. Peuker ET, Filler TJ. The nerve supply of the human auricle. Clin Anat 2002; 15: 35-7.
12. Rub U, Del Tredici K, Schultz C, Thai DR, Braak E, Braak H. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol (Berl) 2001; 101: 555-64.